Home › Compare › BMCS vs PLD

BMCS vs PLD: Dividend Comparison 2026

BMCS yields 181818.18% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMCS wins by $1.8951031795759825e+29M in total portfolio value
10 years
BMCS
BMCS
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full BMCS calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — BMCS vs PLD

📍 BMCS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMCSPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMCS + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BMCS pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMCS
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, BMCS beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMCS + PLD for your $10,000?

BMCS: 50%PLD: 50%
100% PLD50/50100% BMCS
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

BMCS
No analyst data
Altman Z
0.3
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMCS buys
0
PLD buys
0
No recent congressional trades found for BMCS or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMCSPLD
Forward yield181818.18% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$1.8951031795759825e+29M$6.50M ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$5,256,436.18
Total dividends collected$1.8949690612486723e+29M$6.37M ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BMCS vs PLD ($10,000, DRIP)

YearBMCS PortfolioBMCS Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$18,192,518$18,181,818.18$11,255$555.24+$18.18M → BMCS
2$30,932,835,887$30,913,369,892.64$13,062$1,018.59+$30932.82M → BMCS
3$49,156,619,660,049$49,123,521,525,649.34$15,903$1,926.67+$49156619.64M → BMCS
4$73,009,768,971,452,110$72,957,171,388,415,860.00$20,839$3,823.32+$73009768971.43M → BMCS
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$30,464$8,166.08+$101348671691011.73M → BMCS
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$52,054$19,457.30+$131490628941834960.00M → BMCS
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$109,886$54,188.93+$159445709700484431872.00M → BMCS
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$304,030$186,451.18+$1.8070656065589233e+23M → BMCS
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$1,166,125$840,813.32+$1.9141674430419936e+26M → BMCS
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$6,504,190$5,256,436.18+$1.8951031795759825e+29M → BMCS

BMCS vs PLD: Complete Analysis 2026

BMCS — Stock

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Full BMCS Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this BMCS vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMCS vs SCHDBMCS vs JEPIBMCS vs OBMCS vs KOBMCS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.